Cancers | Top 10 Cited Papers in 2023 in the Section “Cancer Immunology and Immunotherapy”

We are pleased to invite you to read the top 10 cited papers published in Cancers (ISSN: 2072-6694) in 2023 in the Section “Cancer Immunology and Immunotherapy”. We hope this announcement will provide useful information for this field.

The list of papers is as follows:

“CAR-T: What Is Next?”
by Yi-Ju Chen, Bams Abila and Yasser Mostafa Kamel
Cancers 2023, 15(3), 663; https://doi.org/10.3390/cancers15030663
Available online: https://www.mdpi.com/2072-6694/15/3/663

“Immunotherapy in Melanoma: Recent Advances and Future Directions”
by Andrew Knight, Lilit Karapetyan and John M. Kirkwood
Cancers 2023, 15(4), 1106; https://doi.org/10.3390/cancers15041106
Available online: http://www.mdpi.com/2072-6694/15/4/1106

“Immunotherapy for Triple-Negative Breast Cancer: Combination Strategies to Improve Outcome”
by Liying Li, Fan Zhang, Zhenyu Liu and Zhimin Fan
Cancers 2023, 15(1), 321; https://doi.org/10.3390/cancers15010321
Available online: http://www.mdpi.com/2072-6694/15/1/321

“Tumor Infiltrating Lymphocytes across Breast Cancer Subtypes: Current Issues for Biomarker Assessment”
by Carmine Valenza, Beatrice Taurelli Salimbeni, Celeste Santoro, Dario Trapani, Gabriele Antonarelli and Giuseppe Curigliano
Cancers 2023, 15(3), 767; https://doi.org/10.3390/cancers15030767
Available online: https://www.mdpi.com/2072-6694/15/3/767

“Emerging Targeted Therapies for HER2-Positive Breast Cancer”
by María Florencia Mercogliano, Sofía Bruni, Florencia Luciana Mauro and Roxana Schillaci
Cancers 2023, 15(7), 1987; https://doi.org/10.3390/cancers15071987
Available online: http://www.mdpi.com/2072-6694/15/7/1987

“Multicenter International Study of the Consensus Immunoscore for the Prediction of Relapse and Survival in Early-Stage Colon Cancer”
by Bernhard Mlecnik, Alessandro Lugli, Gabriela Bindea, Florence Marliot, Carlo Bifulco, Jiun-Kae Jack Lee, Inti Zlobec, Tilman T. Rau, Martin D. Berger, Iris D. Nagtegaal et al.
Cancers 2023, 15(2), 418; https://doi.org/10.3390/cancers15020418
Available online: https://www.mdpi.com/2072-6694/15/2/418

“Alterations in Natural Killer Cells in Colorectal Cancer Patients with Stroma AReactive Invasion Front Areas (SARIFA)”
by Nic G. Reitsam, Bruno Märkl, Sebastian Dintner, Eva Sipos, Przemyslaw Grochowski, Bianca Grosser, Florian Sommer, Stefan Eser, Pia Nerlinger, Frank Jordan et al.
Cancers 2023, 15(3), 994; https://doi.org/10.3390/cancers15030994
Available online: https://www.mdpi.com/2072-6694/15/3/994

“Complement Activation and Up-Regulated Expression of Anaphylatoxin C3a/C3aR in Glioblastoma: Deciphering the Links with TGF-β and VEGF”
by Franck Ah-Pine, Axelle Malaterre-Septembre, Yosra Bedoui, Mohamed Khettab, James W. Neal, Sébastien Freppel and Philippe Gasque
Cancers 2023, 15(9), 2647; https://doi.org/10.3390/cancers15092647
Available online: https://www.mdpi.com/2072-6694/15/9/2647

“mRNA-Lipid Nanoparticle (LNP) Delivery of Humanized EpCAM-CD3 Bispecific Antibody Significantly Blocks Colorectal Cancer Tumor Growth”
by Vita Golubovskaya, John Sienkiewicz, Jinying Sun, Yanwei Huang, Liang Hu, Hua Zhou, Hizkia Harto, Shirley Xu, Robert Berahovich, Walter Bodmer et al.
Cancers 2023, 15(10), 2860; https://doi.org/10.3390/cancers15102860
Available online: https://www.mdpi.com/2072-6694/15/10/2860

“PD-1 Inhibitors in Elderly and Immunocompromised Patients with Advanced or Metastatic Cutaneous Squamous Cell Carcinoma”
by Alexander Yakobson, Ashraf Abu Jama, Omar Abu Saleh, Regina Michlin and Walid Shalata
Cancers 2023, 15(16), 4041; https://doi.org/10.3390/cancers15164041
Available online: http://www.mdpi.com/2072-6694/15/16/4041

You are invited to view and submit relevant papers to the journal Cancers at the following link: https://www.mdpi.com/journal/cancers.

Cancers Editorial Office